Clinical Trial Update: Minnelide and Osimertinib for the Treatment of Advanced EGFR Mutated Non-Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating Minnelide in combination with Osimertinib for advanced EGFR-mutated non-small cell lung cancer; the study is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Minnelide (minnelide)
• Osimertinib (osimertinib)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Advanced Lung Non-Small Cell Carcinoma, Locally Advanced Lung Non-Small Cell Carcinoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING